Nicaise Claude

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 49% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Nicaise Claude's trades of Sarepta Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
401.89
Quantity 33,338
Value US$332,659
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-13 2025-03-12
S Sale
10,588 +26.5%
104.82
US$3,173,113 		10,588 +26.5% 104.82 US$3,173,113
2025-03-12 2025-03-12
PrS Proposed sale
33,338
401.89
US$332,659 		33,338 401.89 US$332,659